Skip to main content
Clinical Trials/NCT01561664
NCT01561664CompletedNot Applicable

Relations Between Obesity and Insulin Resistance: Role of Inflammation Regulatory Mechanisms in Obese Patients Without Associated Comorbidity

University Hospital, Montpellier2 sites in 1 country30 target enrollmentStarted: November 2011Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
30
Locations
2
Primary Endpoint
TLR regulation

Study Overview

Brief Summary

Insulin resistance is one of the main mechanisms involved in metabolic diseases. inflammation has been implicated in its pathogenesis, due to innate immunity activation by free fatty acids, lipopolysaccharides (LPS) and lactate. Free fatty acids, LPS and lactate activate innate immunity in squelettal muscle and adipose tissue via Toll-like receptor 2/4, NFkB, IRF3 (Interferon Responsive Factor 3) and cytokines secretion (TNFa, IFN g, IL1b, IL6), chemokines secretion (MCP1) and leukotrienes (LTB4). Feed back mechanisms involved in TLR signaling pathways as RLI (ribonuclease L inhibitor)/ABCE1, have never been studied in inflammation due to obesity. RLI inhibits an endoribonuclease, RNase L, which has been recently implicated in TLR signaling The purpose of this study is to analyse the role of RLI and RNase L in TLR regulation, and its potential implication in the link between obesity, inflammation and insulin resistance in adipose tissue and squeletal muscle in humans.

Detailed Description

The investigators working hypothesis is that RNase L and RLI contribute to chronic inflammation regulation and to insulin response through TLR 4 pathway regulation in obesity. The investigators main purpose is to compare innate immunity activation pathway between insulin sensitive, insulin resistant obese patients and control patients. Insulin sensitive and insulin resistant obese patients will be distinguish thanks to the HOMA ir index. The investigators second objectives are to evaluate if the degree of inflammation in adipose tissue and squeletal muscle is correlated to insulin sensitivity measured by hyperinsulinemic euglycemic clamp and to characterise inflammatory pathway and regulation pathway. A special focus will be given to the leukotrienes and their potential role in insulin resistance pathogenesis. The investigators will have two approaches:- characterisation of subjects with normal weight, of obese insulin sensitive and obese insulin resistant through a metabolic evaluation, an inflammatory characterisation and a measure of insulin sensitivity at the systemic level, in adipose tissue and in squeletal muscle.- an in vitron approach with human myoblast and adipocytes culture, extracted from the investigators patients: characterisation of inflammation, innate immunity.

Study Design

Study Type
Interventional
Allocation
Non Randomized
Intervention Model
Parallel
Masking
None

Eligibility Criteria

Ages
50 Years to 65 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • Age between 50 and 65 years old
  • Men/ menopausal women
  • BMI <25 kg/m2 for the control group, BMI >30 kg/m2 for the obese group
  • Non diabetic patients
  • HOMAIR <3 for the insulin sensitive obese group
  • Non smoking
  • Without any inflammatory disease
  • Without any first degrees relative with diabetes
  • Without any treatment that could interfere with insulin sensitivity
  • without any infection

Exclusion Criteria

  • Not provided

Arms & Interventions

overweight insulin resistant

Experimental

overweight patients insulin resistant responding to the study criteria

Intervention: muscle and fat biopsy (Other)

volunteers

Active Comparator

not overweight Volunteers responding to the study criteria

Intervention: muscle and fat biopsy (Other)

overweight patients insulin sensitive

Experimental

overweight patients insulin sensitive responding to the study criteria

Intervention: muscle and fat biopsy (Other)

Outcomes

Primary Outcomes

TLR regulation

Time Frame: 2 years

analyse the role of RLI and RNase L in TLR regulation, and its potential implication in the link between obesity, microinflammation and insulin resistance in adipose tissue and squelettal muscle in humans.

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (2)

Loading locations...

Similar Trials

Inflammation Regulation in Obese Patients | Clinical Trial